全球制药行业年度顶级盛会——世界制药原料与技术展会（CPHI Frankfurt）将于2025年10月28日至30日在德国法兰克福国际展览中心（Messe Frankfurt）隆重举行。据预计，本次展会预计将吸引来自全球超过166个国家和地区的62,000名行业专业人士，同时汇聚2,400家顶尖展商，共同聚焦制药前沿技术与未来发展趋势，展开深度交流与探讨。
博腾一直致力于为客户提供从临床前研究到药品上市的全生命周期解决方案，助力创新药物加速上市，推动全球医药行业高质量发展。在这场汇聚全球制药智慧与供应链资源的盛会上，作为全球领先的一站式CDMO服务提供商，博腾股份将携其在小分子药物、多肽与寡核苷酸药物、蛋白与偶联药物以及细胞与基因治疗药物领域的全流程定制研发与生产能力亮相6.0D58展位。
多年来，博腾股份始终秉持着创新与专业的精神，在行业内深耕细作。我们致力于为客户提供从临床前研究到药品上市的全生命周期解决方案。为进一步深化与行业伙伴的交流与合作，博腾股份特别在展会期间精心安排了两场技术演讲，届时将与全球行业领袖共同探讨前沿技术与创新路径，为行业发展注入新的活力。
展台演讲日程如下：
如您希望与博腾专家面对面交流，深入了解博腾在小分子、多肽与寡核苷酸、蛋白与偶联、细胞与基因治疗药物等领域定制研发与生产的创新解决方案，欢迎届时莅临6.0D58展位。在这里，您不仅能获取前沿的行业资讯，更能与我们一同探讨医药发展的无限可能。让我们携手并肩，以专业与热忱为推动全球医药行业的高质量发展注入强劲动力，共同开创医药健康更加美好的未来。
期待与您相约CPHI Frankfurt 2025！
如需预约现场会谈，请：
点击“阅读原文”访问博腾官方网站：线下会议专区
发送邮件至：business@portonpharma.com
博腾股份成立于2005年，主要为全球药企、生物科技公司、科研机构等提供从临床前研究到药品上市全生命周期所需的小分子药物、多肽与寡核苷酸药物、蛋白与偶联药物以及细胞与基因治疗药物等一站式服务解决方案，研发、生产、运营场地覆盖中国（重庆、上海、四川、江苏、江西、湖北）、美国、斯洛文尼亚、比利时、瑞士和丹麦等地。我们始终坚持以客户为中心，致力于为客户提供创新、可靠的全球化、端到端CDMO服务，让好药更早惠及大众。
Frankfurt, Germany – The world's leading pharmaceutical industry gathering, CPHI Frankfurt 2025, is set to take place from October 28 to 30, 2025, at the renowned Messe Frankfurt International Exhibition Centre in Germany. This prestigious event is expected to attract over 62,000 industry professionals and more than 2,400 exhibitors from over 166 countries, fostering innovation and collaboration in pharmaceutical advancements.
Porton Pharma Solutions, a globally recognized pioneer in Contract Development and Manufacturing Organization (CDMO) services, will be showcasing its end-to-end CDMO capabilities, commercial manufacturing, and specialized expertise in Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, RDCs, etc.), as well as Advanced Therapy Medicinal Products at booth 6.0D58. Our commitment to innovation, efficiency, and sustainability positions us as a trusted partner in the pharmaceutical industry.
In addition to exhibiting at booth 6.0D58, Porton will host two technical sessions on Wednesday, October 29th, offering deep dives into critical advancements in pharmaceutical manufacturing. These sessions will provide valuable insights for industry leaders and innovators.
Join us at CPHI Frankfurt 2025 to explore how Porton’s innovative technologies and tailored solutions can drive your pharmaceutical projects forward. We look forward to connecting with you in Frankfurt.
Founded in 2005, Porton Pharma Solutions Ltd. is an internationally recognized pharmaceutical contract development and manufacturing organization (CDMO) in enabling our global clients to optimize drug development and manufacturing. We provide customer development and manufacturing services for Small Molecules, Tides, Biologics and Conjugates (ADCs, AOCs, PDCs, RDCs, etc.), and Advanced Therapy Medicinal Products from pre-clinical to commercialization stages.
中国组展机构：盈拓国际展览，以创新科技和服务体验为核心竞争力，引领中国出境展览服务行业发展。助力企业出海，共赢未来。
下届展会时间：2026年10月06号~10月08号
展会行业：医疗
